Target Price | $7.30 |
Price | $0.72 |
Potential |
909.68%
register free of charge
|
Number of Estimates | 5 |
5 Analysts have issued a price target Coherus BioSciences, Inc. 2025 .
The average Coherus BioSciences, Inc. target price is $7.30.
This is
909.68%
register free of charge
$12.00
1,559.75%
register free of charge
$1.50
107.47%
register free of charge
|
|
A rating was issued by 8 analysts: 6 Analysts recommend Coherus BioSciences, Inc. to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Coherus BioSciences, Inc. stock has an average upside potential 2025 of
909.68%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 257.24 | 260.75 |
21.89% | 1.36% | |
EBITDA Margin | -73.63% | -26.73% |
38.62% | 63.70% | |
Net Margin | -113.30% | 16.38% |
44.80% | 114.46% |
7 Analysts have issued a sales forecast Coherus BioSciences, Inc. 2024 . The average Coherus BioSciences, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Coherus BioSciences, Inc. EBITDA forecast 2024. The average Coherus BioSciences, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Coherus BioSciences, Inc. Analysts have issued a net profit forecast 2024. The average Coherus BioSciences, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.53 | 0.37 |
32.71% | 114.62% | |
P/E | 1.95 | |
EV/Sales | 0.85 |
5 Analysts have issued a Coherus BioSciences, Inc. forecast for earnings per share. The average Coherus BioSciences, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Coherus BioSciences, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Coherus BioSciences, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.